Another study conducted multivariate analysis, identifying preoperative serum GGT as an independent predictor of OS, CSS (cancer-specific survival), and DFS in bladder cancer (BC) patients following radical cystectomy, suggesting its inclusion in prognostic models [28]. The gene discussed is GGT1; the disease is breast cancer.